Aspen increases revenue by 31 percent
Johannesburg – JSE Ltd listed Aspen Pharmacare Holdings Limited (Apn), Africa’s largest pharmaceutical manufacturer, has announced pleasing results for the interim period ended 31 December
Aspen increases revenue by 29 percent to R12.4 billion
Johannesburg – JSE Ltd listed Aspen Pharmacare Holdings Limited, the leading pharmaceutical manufacturer in the southern hemisphere, has produced excellent results for the year ended
Aspen increases revenue by 33 percent
Aspen increases revenue by 33 percent. Johannesburg – JSE Ltd listed Aspen Pharmacare Holdings Limited (Apn), Africa’s largest pharmaceutical manufacturer, has announced pleasing results for
FM’s Nine Questions to Stephen Saad
Nine questions – Stephen Saad Group Chief Executive, Aspen Pharmacare Holdings Limited Xolile Bhengu Thursday, 24 Feb 2011 2011 started off with finalising the Sigma
Aspen granted generic license for the manufacture and supply of TMC278
Johannesburg. Aspen (APN), South Africa’s leading pharmaceutical company, has announced that Irish-based Tibotec Pharmaceuticals has granted it a non-exclusive license to manufacture, market and distribute
Aspen acquires Sigma’s pharmaceutical business for R6,1 billion
Johannesburg. Aspen (APN), South Africa’s leading pharmaceutical company, has announced that all conditions precedent have been met for it to acquire the pharmaceutical business of
Aspen ARV tender bid is successful
Aspen ARV tender bid is successfulFollowing the announcement of the Anti-Retroviral (ARV) Tender results by the South African National Treasury Department, Aspen Pharmacare Holdings Limited
Aspen’s CSI programmes provide increased ARV access to mothers and infants
Aspen’s CSI programmes provide increased ARV access to mothers and infants Johannesburg. Aspen Pharmacare, South Africa’s leading pharmaceutical manufacturer, as part of its continued social
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
